TNIK's emerging role in cancer, metabolism, and age-related diseases
Collin Y Ewald1, Fadi E Pulous2, Sarah Wing Yan Lok3
1Laboratory of Extracellular Matrix Regeneration, Institute of Translational Medicine, Department of Health Sciences and Technology, ETH Zürich, Schwerzenbach CH-8603, Switzerland.
Abstract:
Traf2- and Nck-interacting kinase (TNIK) has emerged as a key regulator of pathological metabolic signaling in several diseases and is a promising drug target. Originally studied for its role in cell migration and proliferation, TNIK possesses several newly identified functions that drive the pathogenesis of multiple diseases. Specifically, we evaluate TNIK's newfound roles in cancer, metabolic disorders, and neuronal function. We emphasize the implications of TNIK signaling in metabolic signaling and evaluate the translational potential of these discoveries. We also highlight how TNIK's role in many biological processes converges upon several hallmarks of aging. We conclude by discussing the therapeutic landscape of TNIK-targeting drugs and the recent success of clinical trials targeting TNIK.
Insights
Traf2- and Nck-interacting kinase (TNIK) is a key regulator in diseases, impacting cancer, metabolic disorders, and neuronal function. Targeting TNIK shows therapeutic promise, with recent clinical trials demonstrating success.
Area of Science:
- Biochemistry
- Molecular Biology
- Pathology
Background:
- Traf2- and Nck-interacting kinase (TNIK) was initially recognized for its roles in cell migration and proliferation.
- Emerging evidence highlights TNIK's significant involvement in the pathogenesis of various diseases.
Purpose of the Study:
- To evaluate the newly identified functions of TNIK in cancer, metabolic disorders, and neuronal function.
- To emphasize TNIK signaling's implications in metabolic pathways and assess its translational potential.
- To explore TNIK's convergence with hallmarks of aging.
Main Methods:
- Literature review and analysis of existing research on TNIK.
- Evaluation of TNIK's role in disease pathogenesis.
- Assessment of clinical trial data for TNIK-targeting drugs.
Main Results:
- TNIK plays a critical role in pathological metabolic signaling across multiple disease contexts.
- TNIK's functions extend to cancer, metabolic disorders, and neuronal function, influencing disease progression.
- TNIK's involvement in biological processes aligns with several hallmarks of aging.
Conclusions:
- TNIK is a promising therapeutic target for a range of diseases due to its role in metabolic signaling.
- Targeting TNIK has demonstrated clinical success, indicating significant translational potential.
- Further research into TNIK signaling may unlock new therapeutic strategies for age-related diseases.
Related Concept Videos
Mitochondria
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
PI3K/mTOR/AKT Signaling Pathway
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Replicative Cell Senescence


